Can New Biomarker Help Identify High-Risk DLBCL Patients? ...Middle East

Medscape - News
Can New Biomarker Help Identify High-Risk DLBCL Patients?
Minimal residual disease-negativity after treatment in DLBCL strongly correlates with remission and overall survival. However, clinical trials are needed to clarify the optimal clinical utility. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Can New Biomarker Help Identify High-Risk DLBCL Patients? )

Also on site :